Company ProfilePremium

Shine Justice Ltd

Company Profile Analysis

Ticker: SHJ.AX

ESOMAR 23 Corporate BadgeISO Certifications Badge
Shine Justice Ltd - Company showcase

Year Founded & Workforce

1976

896 Employees

Shine Justice Ltd logo

Shine Justice Ltd Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Shine Justice Ltd Overview

Shine Justice is one of very few publicly listed law firms globally and the parent of Shine Lawyers, a 50-year-old Australian plaintiff litigation group that operates predominantly on a no-win-no-fee basis. Its economic engine is Personal Injury (86% of FY26 statutory revenue and income), where it holds an estimated 8.5% share of a fragmented A$2.0 billion market and resolves 4,000+ matters a year, securing over A$800 million in damages. The second segment, Class Actions, is a higher-variance, higher-ticket practice that has produced landmark First Nations Stolen Wages settlements and is now being internationalised through a US "hub" (Shine Lawyers US, LLC in Arizona) that sources mass torts for Australian, New Zealand and Thai "spokes". The investment case rests on converting a A$366.6 million work-in-progress (WIP) book into cash, restoring earnings quality after repeated legacy write-downs, and proving that AI-enabled workflows and international mass torts can lift returns from a low single-digit ROE base.


Company's own description (FY26 Annual Report / Presentation)

The company describes itself as an ASX-listed Australian legal group and parent of Shine Lawyers, one of the nation's largest plaintiff law firms, helping everyday people and communities access justice through a predominantly no-win-no-fee model across two operating segments — Personal Injury and Class Actions — with a growing New Zealand and international mass-torts capability (FY26 Investor Presentation, slide 3). The Directors' Report states that during FY26 the Group provided plaintiff legal services in Australia, New Zealand and Arizona, USA, across those two core segments, with no significant change in the nature of activities. Its stated purpose is to "shine a light on injustice" and its values include standing up for "the little guy".

Business model and revenue model

Revenue type (AUD Mn)FY2025FY2026
No-win-no-fee variable (PI)156.9168.3
No-win-no-fee fixed (PI)9.411.3
Time and materials (PI)0.01.3
No-win-no-fee variable (Class Action)28.620.5
Time and materials (Class Action)5.53.3
Insurance (Class Action segment)4.04.3
Interest and other income (Corporate)1.50.2
Total revenue and other income205.9209.4

Shine is a contingent-fee professional services business. It funds legal work and client disbursements (medical reports, expert witnesses, court fees) on balance sheet until a matter resolves, then bills fees from settlement or judgment proceeds. Accounting under AASB 15 recognises revenue over time as work is performed, net of a "constraint" for variable consideration; unbilled work sits on balance sheet as contract assets — work in progress (A$366.6m at 30 Jun 2026, net of a A$129.5m constraint, up from A$105.1m), and recoverable disbursements are carried as a separate fair-valued financial asset (A$102.6m).

FY26 revenue and income mix by contract type (A$m, FY26 AR Note 1A):

On this basis roughly 96% of FY26 revenue is contingent ("service" revenue with success-based pricing); time-and-materials work is ~2% and an insurance-services line ~2%. There is no product, subscription or licensing revenue. No single customer exceeds 10% of revenue (FY26 AR).

Value chain position

Shine sits at the client-acquisition and litigation-execution end of the plaintiff legal value chain: it markets directly to consumers (media agency of record dentsu Queensland appointed September 2025; CMO Shannan Madden), operates an intake/CRM platform built on Salesforce, runs matters through to settlement, and administers settlement distributions in some class actions. Upstream it relies on litigation funders (third-party funding for larger class actions; a new international facility of up to A$40m secured in FY26) and disbursement suppliers. Counterparties are compulsory third-party (CTP) motor insurers, workers' compensation schemes, public liability insurers, institutions (abuse claims), corporates, superannuation trustees and governments.

Customer types and end-markets

Individuals: injured in motor accidents, workplaces, public places, medical settings; survivors of institutional abuse; sufferers of dust diseases; superannuation/total-and-permanent-disability (TPD) insurance claimants.

Groups: in class actions across seven sectors identified in the FY26 portfolio: financial services, First Nations/social justice, shareholder, consumer, employment, medical and environmental.

International mass-tort claimants: in Australia, New Zealand and Asia (Thailand), sourced via the US hub.

Independent characterisation

Economically, Shine resembles a specialty finance business wearing a law-firm wrapper: it deploys working capital into a portfolio of litigation "options" whose payoff timing is controlled by courts, insurers and defendants. Personal Injury behaves like a granular, high-volume, statistically predictable book (5,900 new files, 4,000+ resolutions a year), which supports steady EBITDA of A$30–37m. Class Actions are lumpy, concentrated and binary: single-matter write-downs (A$32.4m Ethicon interest judgment in FY23; A$7.3m mesh revenue reversal in H1 FY24; A$13.0m legacy matter in FY26) have repeatedly overwhelmed segment profits. The key analytical variables are therefore WIP recoverability, constraint levels, cash conversion and funding terms — not revenue growth alone.

Strategy

Stated strategy (2026 AR, Operating and Financial Review)

Shine's strategy rests on six pillars: prioritise our client; engage our people; grow Shine; strengthen Shine; innovate Shine; and — added by the Board in FY26 — internationalise Shine, recognising the US presence as central to the Group's future. The FY26 Presentation organises the agenda into three workstreams:

Scale Personal Injury: maintain productivity and recoverability momentum; grow suitable file volumes; pursue disciplined acquisitions; improve conversion and branch performance.

Build the Class Action Engine: raise investigation-to-filing velocity; improve matter selection and governance; advance external funding; progress Australian, NZ, Thai and other international opportunities.

Improve Cash and Efficiency: convert WIP into billed fees and cash; scale technology-supported workflows; maintain cost and capital discipline; preserve facility and covenant headroom.

Initiatives announced in the last 24 months

InitiativeTimingDetail / targetSource
Shine Lawyers US, LLC (Arizona)FY25ABS-licensed entity allowing non-lawyer ownership; IMT hubFY25 Results; 2026 AR
International mass torts hub-and-spoke modelFY25–FY26Source large US mass torts, export to AU/NZ/Asia spokes, secure funding, litigateFY26 Presentation
A$40m international funding facilityFY26Funds a large-scale mass tort class action in Australia2026 AR
Shine Lawyers (Thailand) Co. LtdFY26Asia spoke; Morrison-affiliated, loan-funded2026 AR
Emerging Technology Centre and AI roadmapFY25–FY28Foundation (FY25), proof of concept (FY26), acceleration (FY27), maturity with agentic workflows (FY28)FY26 Presentation
Class action portfolio fundingFY26–FY27"Well progressed" discussions to fund a portfolio of matters, reducing timing riskFY26 Presentation
PI file acquisitionsFY26180 files acquired, "opportunity for more"FY26 Presentation
Disbursement refinancingFY25–FY26Final externally funded disbursements moved to bank facility for interest savings2026 AR
Bank facilities renewed and extendedFY25A$119.7m facilities to March 2028FY25 Results; FY26 Presentation
Capital managementSep 2024 – Oct 2026Buy-backs; fully franked dividends with 30–50% NPAT payout policy2026 AR
Marketing re-platformSep 2025dentsu Queensland media agency of recorddentsu release
Regional outreach program2,026Tours to regional, rural, remote communities2026 AR
Third Reconciliation Action PlanFY26Second "Innovate" RAP being finalised2026 AR

Guidance and medium-term targets

No quantified medium-term targets are published. FY27 guidance is qualitative: the Board "expects to deliver improved EBITDA and operating cash flow in FY27 across our personal injury, class action and emerging international mass tort practice" (Chairman's Letter), with growth in profitability in both segments alongside higher group cash flow (FY26 Presentation). Implicit LTI targets — 8–10% p.a. EPS growth from a 12c base and 15–17% p.a. TSR through FY28 — indicate management's aspirational trajectory.

Products & Services

Pricing across PI is predominantly no-win-no-fee (fees regulated in several states); class actions use contingency structures, funder commissions, Federal Court/Victorian group costs orders (GCOs) and uplift fees. Launch years are generally not disclosed for practice areas.

Personal Injury segment (FY26 revenue and income A$180.9m)

Service lineDescription and capabilitiesTarget clientPricing model
Motor vehicle accident / CTP claimsStatutory and common law claims under state CTP schemesInjured drivers, passengers, pedestrians, cyclistsNo-win-no-fee; regulated in some states
Workers' compensationStatutory benefits and common law damages; Morrison is a QLS Accredited Specialist in PIInjured workersNo-win-no-fee
Public liabilitySlip-and-fall, occupiers' liability, product injuryGeneral publicNo-win-no-fee
Medical law (medical negligence)Clinical negligence claims; cited as a FY23 growth driverPatients and familiesNo-win-no-fee
Abuse lawInstitutional child sexual abuse claims; CLO Lisa Flynn provided evidence to Royal CommissionsSurvivorsNo-win-no-fee
Dust diseasesAsbestos, silica claims; record A$3.2m judgment in NSW Dust Diseases Tribunal (FY25)Mesothelioma/silicosis sufferersNo-win-no-fee
Superannuation and disability insuranceTPD, income protection, life insurance claimsSuper fund membersNo-win-no-fee; fixed-fee (A$11.3m FY26)
Stephen Browne Lawyers (WA brand)Western Australian PI subsidiary brandWA claimantsNo-win-no-fee
Shine Lawyers NZAccident and insurance recovery work in NZ (affiliate consolidated from 7 Nov 2024)NZ claimantsMixed

FY26 PI KPIs: 5,900+ new files; 4,000+ clients compensated; A$800m+ damages; 180 files acquired; new file fees +9%; 47 PI offices; 540+ PI staff (FY26 Presentation; 2026 AR).

Class Action segment (FY26 adjusted revenue A$39.4m)

Service line / flagship matterDescriptionStatus (latest disclosed)
Domestic class actions — financial servicesSuper insurance overcharging (Colonial First State/CMLA/AIA, A$140m; QSuper A$67m; CommInsure two settlements; AMP)CFS settlement hearing scheduled 25 Mar 2026 (Federal Court notice); AMP Super proceedings filed
Shareholder class actionsEML Payments (A$37.2–37.3m settlement; 24.5% GCO)Settled; fee variation bid withdrawn (Lawyerly)
First Nations / social justiceNT Stolen Wages (up to A$202m), WA Stolen Wages (up to A$180.4m); WA and NSW child-removal discrimination actionsStolen Wages paid to majority of members; discrimination actions ongoing
EmploymentKFC rest breaks (A$28.8m, with Gordon Legal, RAFFWU/SDA); SA Sunday penalty rates; other retail rest-break actions (Coles, Woolworths, McDonald's, Big W, Hungry Jack's alleged)KFC final approval hearing scheduled Sep 2026
Consumer, medical, environmentalPipeline incl. pharmaceuticals, product liability; historical mesh, contamination (Wreck Bay, multi-site PFAS) matters6 consumer and 6 medical matters under investigation
International mass torts (IMT)US hub (Shine Lawyers US, LLC, Arizona) sources mass torts for AU/NZ/Thailand spokes; A$40m funding facilitySeveral investigations "well progressed"
New Zealand class actionsHino Motors (first NZ class action win/settlement)Resolved FY26
Commercial disputesLegacy practiceIn wind-down
Family lawSmall T&M practice within CA segmentOngoing
Insurance servicesA$4.3m FY26 revenue under AASB 17 (Note 9)Ongoing

Portfolio at FY26: ~48 open matters — 26 active, 22 investigations; filed actions led by financial services (7) (FY26 Presentation). Six in-principle settlements in FY26 totalling >A$290m.

Technology platforms (internal, not sold)

PlatformCapabilityYear
Emerging Technology CentreCluster of data scientists and IT staff governed by steering committeeEstablished FY25; scaled FY26
AI governance frameworkEnterprise policy for procurement, development, deployment of AIImplemented FY26
Agentic and automation platformFoundation for workflow automation and AI agentsEstablished FY26
Salesforce client intakeCRM for enquiry management, now AI-enhancedDeployed FY25
Data platformReporting, analytics, future AIEstablished FY26
People and payroll platformUnified HR/payrollImplementation commenced FY26

Financial Narrative

Margins and growth

Adjusted margins for FY26 use adjusted revenue of A$220.4m. Revenue CAGR FY22–FY26: –0.7% p.a. (statutory, restated basis). On an adjusted basis FY26 revenue of A$220.4m implies a +0.6% CAGR from FY22.

Commentary. The five-year arc is a sharp de-rating of earnings quality. FY22 was the high-water mark (29.5% statutory EBITDA margin), inflated by class action fee recognition. FY23 was hit by the A$32.4m Ethicon interest judgment; FY24 by A$7.3m of mesh revenue reversals and restructuring costs; FY25 by a A$9.6m deferred consideration write-down; FY26 by the A$13.0m legacy class action charge. The recurring nature of "one-off" items is itself the most important analytical finding: adjusted EBITDA has averaged A$50.7m over five years while statutory EBITDA averaged A$37.8m. The constructive inflection in FY26 is in Personal Injury, where EBITDA grew 18.4% and margins expanded, and in cost control (employee costs +3.8% vs adjusted revenue +7.8%).

Balance sheet (30 June)

Sources: 2026 AR balance sheet; FY24 cash from 2026 AR cash flow opening balance; FY24 WIP from FY25 results; FY24 equity from 2026 AR statement of changes in equity; NTA per Appendix 4E/InvestSMART. The large deferred tax liability reflects tax being payable only when WIP is billed.

Cash flow

Commentary. Operating cash flow has been stable at ~A$19m but is not covering dividends plus lease payments plus capex: FY26 post-lease FCF of A$7.0m funded less than the A$8.5m dividend, with the shortfall drawn from cash. The FY25 refinancing of disbursement funding into bank debt lowered the P&L finance cost (–14%) but raised cash interest paid (A$10.6m vs A$8.0m). Management guides to higher operating cash flow in FY27 as WIP converts.

Ratios

All ratios are analyst calculations from 2026 AR figures except payout (2026 AR). A conventional cash conversion cycle is not meaningful; WIP days of ~640 (i.e., roughly 21 months of revenue tied up in unbilled work) is the relevant working-capital metric. Facility headroom was A$41.4m on A$119.7m of facilities maturing March 2028; all covenants met (FY26 Presentation).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Segment Overview

SegmentWhat it containsKey services

Personal Injury

Core damages-based plaintiff practice

Motor accidents (CTP), workers' compensation, public liability, medical law, abuse law, dust diseases; superannuation and disability insurance claims

Class Action

Growth practice

Domestic class actions, international mass torts (IMT), commercial disputes (in wind-down), family law, insurance services line

Other

Corporate

Head office, group services, interest income

Revenue by Segment

Segment metricFY2024FY2025FY2026

Personal Injury revenue and income (AUD Mn)

—166.3180.9

Class Action revenue and income — statutory (AUD Mn)

—38.128.2

Class Action revenue — adjusted (AUD Mn)

35.038.139.4

Other / corporate income (AUD Mn)

—1.50.3

Group revenue and income (AUD Mn)

—205.9209.4

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Results by Segment and Segment Margins & Growth (%)

Segment metricFY2024FY2025FY2026

Personal Injury EBITDA (AUD Mn)

—30.936.6

Personal Injury EBITDA margin (%)

—18.620.2

Class Action EBITDA — statutory (AUD Mn)

—7.7-4.8

Class Action EBITDA — adjusted (AUD Mn)

8.37.78.2

Class Action adjusted EBITDA margin (%)

23.720.220.8

Other / corporate EBITDA (AUD Mn)

—-9.0-0.1

Group statutory EBITDA (AUD Mn)

34.729.731.7

Segment growth and mix (%)

Segment growth and mix (%)FY2025FY2026

Personal Injury revenue YoY growth (%)

—8.8

Personal Injury EBITDA YoY growth (%)

—18.4

Class Action adjusted revenue YoY growth (%)

8.93.4

Class Action adjusted EBITDA YoY growth (%)

-7.26.5

Personal Injury share of group revenue and income (%)

80.886.4

Class Action share of group revenue and income (%)

18.513.5

Segment cost and capital (AUD Mn)

Segment cost and capital (AUD Mn)FY2025FY2026

PI employee benefits

69.171.4

PI other expenses

18.219.6

PI inter-segment recharges

48.153.3

CA employee benefits

19.118.3

CA other expenses

4.07.1

CA inter-segment recharges

7.37.5

PI segment assets

463.4483.2

CA segment assets

109.890.1

PI segment liabilities

99.899.1

CA segment liabilities

44.944.3

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue (AUD Mn)

215.1226.2195.7204.4209.2

EBITDA — statutory (AUD Mn)

63.429.634.729.731.7

EBITDA — adjusted (AUD Mn)

63.161.645.039.344.7

Depreciation and amortisation (AUD Mn)

——15.416.013.6

EBIT / operating income (AUD Mn)

——19.313.718.1

Finance costs (AUD Mn)

———9.27.9

Profit before tax (AUD Mn)

———4.510.2

NPAT — total incl. NCI (AUD Mn)

31.23.36.00.16.7

NPAT attributable to owners (AUD Mn)

31.13.36.00.69.6

NPAT — adjusted (AUD Mn)

———9.715.8

Basic EPS (A$ cents)

18.01.923.510.335.74

Diluted EPS (A$ cents)

———0.335.66

Adjusted basic EPS (A$ cents)

———5.9611.19

Dividends per share (A$ cents)

6.01.55.55.04.0

Cash Contribution / GOCF (AUD Mn)

30.7-3.951.830.629.4

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Statutory EBITDA margin (%)

29.513.117.714.515.2

Adjusted EBITDA margin (%)

29.327.223.019.220.3

EBIT margin (%)

——9.96.78.7

Net margin — attributable (%)

14.51.53.10.34.6

Revenue growth YoY (%)

—5.2-13.54.42.3

Balance Sheet and Per-Share Data

MetricFY2024FY2025FY2026

Total assets (AUD Mn)

—575.5575.1

Cash and equivalents (AUD Mn)

29.418.112.5

Contract assets — WIP (AUD Mn)

356.4363.5366.6

Unbilled disbursements (AUD Mn)

—100.8102.6

Intangibles incl. goodwill (AUD Mn)

—46.443.7

Borrowings — current (AUD Mn)

—26.628.7

Borrowings — non-current (AUD Mn)

—45.045.0

Lease liabilities (AUD Mn)

—27.425.1

Disbursement creditors (AUD Mn)

—71.470.5

Net debt incl. leases (AUD Mn)

—81.086.3

Deferred tax liability (AUD Mn)

—115.2112.9

Total equity (AUD Mn)

272.6261.3259.7

Equity attributable to owners (AUD Mn)

—261.6262.9

Current assets (AUD Mn)

—248.4273.1

Current liabilities (AUD Mn)

—130.5137.3

Working capital (AUD Mn)

—117.9135.8

WIP revenue constraint (AUD Mn)

—105.1129.5

NTA per share (AUD)

1.321.291.30

Cash Flow

MetricFY2025FY2026

Receipts from customers (AUD Mn)

217.5220.7

Net disbursements paid (AUD Mn)

-10.2-6.3

Interest paid net (AUD Mn)

-7.2-10.5

Income taxes paid (AUD Mn)

-6.2-3.4

Operating cash flow (AUD Mn)

19.519.0

Capex — plant and equipment (AUD Mn)

1.62.7

Capex — intangibles (AUD Mn)

0.80.7

Free cash flow pre-leases (AUD Mn)

17.215.6

Lease principal payments (AUD Mn)

9.28.6

Free cash flow post-leases (AUD Mn)

7.97.0

Dividends paid to shareholders (AUD Mn)

9.58.5

Share buy-backs (AUD Mn)

2.50.3

Net change in cash (AUD Mn)

-11.4-5.5

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2025FY2026

ROE — attributable NPAT / avg owners' equity (%)

0.23.7

ROE — adjusted NPAT basis (%)

3.66.0

ROA — total NPAT / avg assets (%)

0.01.2

ROIC — EBIT x (1-30%) / (equity + net debt) (%)

2.83.7

Current ratio (x)

1.901.99

Debt to equity — borrowings plus leases (x)

0.380.38

Net debt to statutory EBITDA (x)

2.732.72

Net debt to adjusted EBITDA (x)

2.061.93

Interest coverage — EBIT / finance costs (x)

1.52.3

Asset turnover (x)

0.350.36

WIP days — WIP / revenue x 365 (days)

649640

Dividend payout — of attributable NPAT (%)

1,49071

Revenue by Region and Region Margins & Growth (%)

RegionFY2025FY2026

Australia revenue (AUD Mn)

203.0207.2

New Zealand revenue (AUD Mn)

1.52.0

Total revenue (AUD Mn)

204.4209.2

Region growth and mix

FY2026

—

Australia revenue growth YoY (%)

2.1—

New Zealand revenue growth YoY (%)

33.7—

Australia share of revenue (%)

99.1—

New Zealand share of revenue (%)

0.9—

Region Assets & Liabilities

RegionFY2025FY2026

Australia non-current assets (AUD Mn)

270.3249.6

New Zealand non-current assets (AUD Mn)

7.77.4

Share Price and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Share price at 30 June (AUD)

1.080.690.710.700.60

Total shareholder return (%)

7.7-32.94.86.5-8.8

Dividends declared (AUD Mn)

10.42.69.58.56.8

Market capitalisation (AUD Mn)

——122119101

Performance Window Details

Performance windowPrice change (%)Notes

1-year (Jun 2025 → Jun 2026)

-14.3

TSR –8.8% incl. dividends

3-year (Jun 2023 → Jun 2026)

-13.0—

4-year (Jun 2022 → Jun 2026)

-44.4—

Since IPO (A$1.00, May 2013)

-35.5

All-time high A$3.45 (Halo Technologies)

Latest observed

A$0.645 (29 Sep 2026)

2026 range A$0.565–0.77

Valuation Multiples

MultipleShine (statutory)Shine (adjusted)Peers

P/E (x)

11.25.8

No listed pure-play peer

EV/EBITDA (x)

6.24.4—

EV/Sales (x)

0.930.89—

P/B (x)

0.410.41—

P/NTA (x)

0.500.50—

Dividend yield, fully franked (%)

6.26.2—

“—” = not publicly disclosed.

Per-Share Data and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Interim DPS (A$ cents)

—1.51.51.51.5

Final DPS (A$ cents)

—0.04.03.52.5

Total DPS (A$ cents)

6.01.55.55.04.0

Franking (%)

——0100100

Payout ratio of attributable NPAT (%)

33781581,49071

Capital Programmes

ProgramPeriodShares cancelledCost

Initial on-market buy-back

Sep 2024 – Sep 2025

3,871,416

A$2,759,775

Renewed 10% buy-back (max 16,939,039)

3 Oct 2025 – 2 Oct 2026

0 per 2026 AR

Nil

Capital Markets

ItemDetail

Moody's / S&P / Fitch ratings

Not rated (no public credit ratings)

Facilities

A$119.7m total; A$41.4m undrawn headroom; market-rate facility to March 2028

Borrowings

A$73.7m (A$28.7m current, A$45.0m non-current)

Lease liabilities

A$25.1m (A$8.2m current)

Covenants

All complied with in FY26

Analyst Conclusions

Management guidance

The Board expects improved EBITDA and operating cash flow in FY27 across Personal Injury, Class Actions and the emerging IMT practice (Chairman's Letter, 28 Aug 2026). PI momentum in fee earner productivity, write-offs, fees billed and resolution quantum is expected to carry into FY27; Class Actions will focus on filing more matters and finalising litigation funding; the IMT hub will continue sourcing matters globally (FY26 Presentation). No numerical guidance is provided.

Consensus expectations

Formal consensus is not publicly verifiable. Simply Wall St's community narrative models ~5% p.a. revenue growth, a 7% profit margin and an A$0.99 fair value — treat as indicative only.

Bull case

  1. PI earnings power is under-appreciated. PI alone generated A$36.6m EBITDA (+18.4%) in FY26; at a conservative 5x EV/EBITDA on PI alone (A$183m) the market is ascribing little to the Class Action book and nothing to IMT.

  2. Asset backing and yield. The stock trades at ~0.5x NTA (A$1.30) with a 6.2% fully franked yield; A$366.6m of WIP is a contractual pipeline that converts into fees as matters settle.

  3. Catalyst-rich class action pipeline. CFS A$140m, KFC A$28.8m, CommInsure and AMP settlements, plus a portfolio funding deal, could lift FY27 cash flow and re-rate earnings quality; an appeal win on the legacy matter offers upside.

Bear case

  1. "Adjusted" is the norm, not the exception. Four consecutive years of material write-downs (A$62m cumulative FY23–FY26) imply that statutory, not adjusted, earnings are the right base — and on that basis ROE is ~4%.

  2. Cash does not cover distributions. Post-lease FCF of A$7.0m vs A$8.5m dividends, cash down to A$12.5m and net debt up to A$86.3m constrain capital returns; the unused buy-back underlines this.

  3. International expansion adds risk and related-party complexity. IMT affiliates in NZ and Thailand are funded by loans to Morrison-related entities, NZ NCI losses widened to A$2.9m, and the payoff is unquantified and long-dated.

Catalysts and monitorables (next 12 months)

Catalyst / monitorableExpected timingWhy it matters
October 2026 AGM; board renewal post-BayesOct 2026Independence and skills mix
Decision on appeal of legacy interlocutory judgmentFY27 H1Potential reversal of part of A$13.7m
KFC settlement final approval and distributionLate 2026 – early 2027CA cash receipt
CFS A$140m settlement cash receiptFY27Largest pending CA fee event
Class action portfolio funding facilityFY27Timing risk reduction, balance sheet relief
First IMT-sourced filing using A$40m facilityFY27Proof of concept for international strategy
H1 FY27 results (expected late Feb 2027)Feb 2027Cash conversion, constraint trends, PI growth
Buy-back renewal decisionPost-Oct 2026Capital allocation signal
Tort reform announcements in QLD, NSW, VIC, WAOngoingPI fee pool risk
Net debt and facility headroom vs A$41.4mOngoingLiquidity

Analyst verdict

Shine Justice is a structurally sound but chronically under-earning business whose valuation now discounts most of its problems. The core Personal Injury franchise is the best it has looked in years: record fees billed, 8.8% revenue growth, an 18.4% EBITDA uplift and margin expansion achieved alongside lower staff turnover. That franchise, built over 50 years and carrying an 8.5% share of a fragmented A$2.0 billion market, is the bedrock of value and is plausibly worth the entire enterprise value on its own.

The problem is everything around it. Class Actions have generated headline-grabbing social justice outcomes but have also produced a write-down in every one of the last four years, eroding management credibility and making "adjusted" earnings an unreliable anchor. Cash conversion remains weak: operating cash flow of A$19 million on A$31.7 million of statutory EBITDA, dividends exceeding post-lease free cash flow, cash falling to A$12.5 million and net debt rising to A$86.3 million. Governance is adequate rather than strong, with founder control near 50% and related-party funding of international affiliates.

At roughly 0.5x NTA, 6x statutory EV/EBITDA and a 6% fully franked yield, the market is pricing Shine as a value trap. We think the more probable FY27 path is moderate improvement — PI growth persisting, settlement cash from CFS and KFC, and a portfolio funding facility reducing timing risk — but the burden of proof sits with management to deliver a clean year with no material write-downs and operating cash flow that comfortably covers dividends. The international mass torts strategy is an option, not a thesis, until a funded IMT matter is filed and progressed.

Stance (analyst view, not investment advice): Neutral-to-constructive on valuation, with conviction contingent on two milestones in FY27 — a write-down-free result and operating cash flow above A$25 million. Failure on either would confirm the bear case that statutory ROE of ~4% is the business's true earning power.


All figures are A$ and drawn from company filings unless otherwise labelled. Analyst calculations are identified as such.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameRoleIndependenceCommitteesBackground

Graham Bradley AO

Chairman, NED

Independent

Chair, Nomination & Remuneration; member, Audit & Risk

BA, LLB (Hons 1), LL.M (Harvard), FAICD. Former MD Perpetual; CEO Blake Dawson; McKinsey; ex-chair Stockland, United Malt, HSBC Australia, EnergyAustralia; ex-president Business Council of Australia. Current chair Virgin Australia International Holdings, Infrastructure NSW

Teresa Dyson

NED

Independent

Chair, Audit & Risk; member, N&R

BA, LLB (Hons), CPA, MTax, MAppFin, FAICD. Chair Southern Cross Media Group and Humm Group; Takeovers Panel member; ex-Seven West Media, Genex Power

David Bayes

NED

Independent

Member, Audit & Risk and N&R

FAICD (Life). Ex-director Sigma Healthcare; ex-CEO Choice Hotels Australasia, Bakers Delight; ex-McDonald's Australia VP. Director since early 2020; not seeking re-election at October 2026 AGM

Rod Douglas

NED

Not classified as independent in KMP table

None (invitee)

MBA (Bond), FAICD; 30+ years advising founder and family businesses

Simon Morrison

Executive Director – International Mass Torts (MD to 14 Apr 2026)

Executive; substantial shareholder

—

LLB. Joined 1988 as articled clerk; MD 15+ years; former National President, Australian Lawyers Alliance; AAJ Board of Governors; QLS Accredited Specialist (PI)

Executive Leadership Team

NameTitleTenurePrior roles / education

Carolyn Barker AM

Group Chief Executive Officer (also "Chief Change Officer")

Shine NED 2009–2020; returned as executive 2023; Group CEO from Feb 2025; enhanced role Apr 2026

BBus, MBA, FAIM (Life). Three-decade executive career incl. private-equity-owned businesses; ex-chair Queensland Symphony Orchestra; Member of the Order of Australia (2005)

Marc Devine

CFO and Company Secretary

From 23 Sep 2024

BBus (Acc), FCPA, GAICD. Ex-CFO and Co Sec, Alliance Aviation Services; Mater Health; Metro North HHS

Lisa Flynn

Chief Legal Officer

Long-serving (start date not disclosed)

LLB (Hons 1), B Com (Hons 1); abuse law specialist; INSEAD executive education

Jodie Willey

COO, seconded as Head of Victoria

COO since 2019; CEO at time of 2013 listing

LLB (Hons); Accredited Specialist PI

Annette O'Hara

General Counsel and Company Secretary

Since Feb 2017

BA, LLB (Hons 1), FGIA; ex-Corrs Chambers Westgarth; Company Secretary of the Year 2022

Shannan Madden

Chief Marketing Officer, Shine Lawyers

—

dentsu release (Sep 2025)

“—” = not publicly disclosed.

Directors' Remuneration

ExecutiveSalary and feesSTIOtherSuperShare-basedOther LTTotal FY26Total FY25

Simon Morrison

549,285044,79030,000035,262659,337570,615

Carolyn Barker AM

447,3890138,34130,00020,6608,677645,067236,697

Marc Devine

442,628011,07730,00020,73213,649518,086368,952

Jodie Willey

440,417011,07730,00047,407-5,361523,540492,419

Lisa Flynn

449,7840030,00048,671-5,277523,178532,871

Total Executive KMP

2,329,5030205,285150,000137,47046,9502,869,2082,423,683

NED

Fees

NED rights

Super

Total FY26

————

Graham Bradley AO

205,63279,73824,676310,046————

Teresa Dyson

118,44415,31014,213147,967————

David Bayes

105,28430,61912,634148,537————

Rod Douglas

105,28430,61912,634148,537————

Board & Management Changes

DateChange

23–27 Sep 2024

Marc Devine replaces Ravin Raj as CFO; joint Company Secretary from Dec 2024

Feb 2025

Carolyn Barker AM appointed Group CEO

14–15 Apr 2026

Morrison moves from MD to Executive Director – IMT; Barker becomes overall leader and CODM

Oct 2026 (AGM)

David Bayes retiring from board

Major Shareholders

HolderSharesStake (%)Source / date

Simon Morrison (individual and nominees)

43,718,70425.8

2026 AR (42,339,902 + 1,378,802)

Stephen Roche (co-founder)

~43.7 million

~25.8

Simply Wall St (date not specified)

Morrison + Roche combined voting power (associated)

—50.34

ASX substantial holder notices (via TipRanks)

Iolite Partners Limited

19,050,000

11.0–11.2

Substantial holder notice; Simply Wall St

Fidelity International

17,109,88810.1

Simply Wall St (may be stale)

NCH Pty Ltd

3,212,9381.9

Simply Wall St

Lev Mizikovsky

2,361,1831.4

Simply Wall St

Dimensional Fund Advisors

2,014,7951.2

Simply Wall St

Jodie Willey

1,854,2731.1

2026 AR

Graham Bradley AO

753,6970.4

2026 AR

Lisa Flynn

509,8930.3

2026 AR

Competitive Landscape

Key Competitors

CompetitorOwnershipSegments competedRelative positioning

Slater and Gordon (Allegro Funds)

Private equity (delisted 2021)

PI, class actions

IBISWorld names Allegro Funds the largest operator in Australian PI; national brand

Maurice Blackburn

Private partnership

PI, class actions, employment

Leading plaintiff and class action firm; strong union alignment

Carbone Lawyers

Private

PI (NSW focus)

High-volume PI specialist

Turner Freeman

Private

PI, dust diseases

Dust disease leader

Stacks Law Firm

Private

PI (NSW)

Regional NSW network

Gordon Legal

Private

Class actions, employment, PI

Also co-counsel with Shine (KFC)

Phi Finney McDonald

Private

Class actions (shareholder, consumer)

Specialist class action firm

William Roberts Lawyers

Private

Class actions (shareholder, social justice)

Specialist class action firm

Piper Alderman

Private

Class actions (funded)

Commercial firm with class action practice

Banton Group

Private

Class actions

Specialist class action firm

Omni Bridgeway (ASX: OBL)

Listed

Litigation funding (partner/competitor for economics)

Funder capturing part of CA economics

Ramsden Lawyers

Private

PI

Named by CB Insights as competitor

Competitor Detail

MetricShine Justice FY2026

Revenue (AUD Mn)

209.2

Revenue growth (%)

2.3

Statutory EBITDA margin (%)

15.2

Technology spend % revenue (%)

5.9

Company Snapshot

$135M

Revenue

896

Employees

1976

Founded

Brisbane, Australia

Headquarters

SWOT Analysis

Strengths

  • PI scale and profitability: FY26 PI revenue A$180.9m (+8.8%) and EBITDA A$36.6m (+18.4%), margin 20.2% (2026 AR).
  • Market leadership: 8.5% share of a A$2.0bn market where 73.2% is held by smaller firms (IBISWorld via FY26 Presentation).
  • Track record: A$12bn+ damages for 233,000+ clients since inception; A$1bn+ in FY26 alone (2026 AR).
  • Class action credentials: Stolen Wages settlements totalling A$380m+; six in-principle settlements >A$290m in FY26 (FY26 Presentation).
  • Book value support: NTA A$1.30/share vs share price ~A$0.645 (Appendix 4E).
  • Liquidity and covenants: A$41.4m headroom on A$119.7m facilities to March 2028; all covenants met (FY26 Presentation).
  • Franking capacity: A$6.1m franking credits supporting fully franked dividends (FY26 Presentation).

Weaknesses

  • Serial "one-offs": material write-downs in each of FY23 (A$32.4m), FY24 (A$7.3m), FY25 (A$9.6m) and FY26 (A$13.0m) (company announcements).
  • Low returns: ROE 3.7% and ROIC ~3.7% in FY26 (analyst calculation from 2026 AR).
  • Cash conversion: operating cash flow A$19.0m vs statutory EBITDA A$31.7m; post-lease FCF A$7.0m below dividends of A$8.5m (2026 AR).
  • WIP intensity: A$366.6m WIP (~640 days of revenue) and a constraint that rose to A$129.5m (2026 AR).
  • Rising net debt: A$86.3m (+6.5%); cash fell to A$12.5m (FY26 Presentation).
  • Incentive misses: no STI for two consecutive years; FY23 LTI vested at 5% (2026 AR).
  • Related-party complexity: A$10.3m loans to Morrison-affiliated NZ entity, Thai entity loans, and leases from Morrison-controlled entities (2026 AR Note 11).

Opportunities

  • IMT hub: A$40m funding facility in place; "several mass tort investigations well progressed" (2026 AR).
  • Pipeline conversion: 22 investigation matters, including 6 consumer and 6 medical, could convert to revenue upon filing (FY26 Presentation).
  • Portfolio funding: a class action portfolio facility would reduce timing risk and free balance sheet (FY26 Presentation).
  • AI operating leverage: IT spend rose to A$12.4m; FY27–FY28 roadmap targets automation across the matter lifecycle (FY26 Presentation).
  • Consolidation: 1,400+ PI firms averaging 5.4 staff; 180 files acquired in FY26 with "opportunity for more" (IBISWorld; FY26 Presentation).
  • Employment class actions: KFC A$28.8m precedent may foreshadow larger rest-break proceedings against other retailers (KWM).
  • Legacy appeal: a successful appeal of the FY26 interlocutory judgment could reverse part of the A$13.7m write-down (ASX, 21 Aug 2026).

Threats

  • Tort reform: explicitly cited by the Board as a risk across jurisdictions (2026 AR).
  • Judicial fee scrutiny: EML fee-variation criticism (Lawyerly) and historical judicial criticism of fees (Wikipedia).
  • Court and administrative delays: drove negative H1 FY26 GOCF of –A$6.3m (Appendix 4D summary).
  • Competition from PE-backed Slater and Gordon and partnership firms (IBISWorld).
  • International execution risk: different legal systems, funding, data protection and regulatory regimes (2026 AR risk section).
  • Cyber/AI risk: confidential client data and AI output reliability (2026 AR).
  • Key-person/control risk: founder-shareholders control ~50.3% of votes (substantial holder notices).

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
2 Apr 2025Iolite Partners buys 525,000 shares at up to A$0.83 Simply Wall StContinued accumulation by substantial holder
2025 (date not specified)Iolite lifts voting power from 9.98% to 11.0% TipRanksThird-largest holder strengthens position
FY25Shine Lawyers US, LLC established in Arizona FY25 ResultsFoundation of IMT strategy
28 Aug 2025FY25 results: revenue A$204.4m (+4.4%); statutory NPAT A$0.1m; A$9.6m deferred consideration write-down; 3.5c final dividend FY25 ResultsFirst franked dividends since 2018
Sep 2025Initial buy-back completes: 3.87m shares for A$2.76m 2026 ARCapital return
17 Sep 2025New on-market buy-back of up to 16.94m shares (10%), 3 Oct 2025 – 2 Oct 2026, via Morgans ASX noticeOptional capital lever; no shares bought under it per 2026 AR
18 Sep 2025dentsu Queensland appointed media agency of recordMarketing efficiency for client acquisition
Sep–Oct 2025Directors Dyson (A$35.8k) and Bayes (A$28.7k) buy shares on market StockLightBoard alignment signal
15 Oct 2025FY25 final dividend 3.5c paid 2026 ARShareholder return
Oct 2025AGM; remuneration report 97.8% approval 2026 ARGovernance
Nov 2025In-principle A$140m Colonial First State/CMLA/AIA settlement (~700,000 super members) FY26 Presentation; LawyerlyLargest FY26 CA settlement
FY26 (date not disclosed)Two CommInsure class actions settle within two days LawyerlyFinancial services pipeline monetising
FY26Judge criticises Shine's application to vary 24.5% GCO in EML settlement; Shine withdraws A$2m uplift bid LawyerlyFee-governance reputational risk
6 Feb 2026KFC rest breaks settlement terms (A$28.8m) announced with majority of 89 franchisees KWM; The Daily AusFirst rest-break class action settlement in Australia
27 Feb 2026H1 FY26: revenue A$108.8m (+8%), EBITDA A$21.1m (+77%), NPAT A$6.7m vs –A$1.7m; 1.5c interim; negative GOCF –A$6.3m from court delays Appendix 4D; Investing.comTurnaround confirmed; cash lag flagged
Feb 2026Additional on-market buy-back notice StockLightCapital management
25 Mar 2026Federal Court settlement approval hearing scheduled for CFS action Federal Court noticePath to cash receipt
April 202650th anniversary gala at Brisbane City Hall QLS ProctorBrand milestone
14–15 Apr 2026Morrison steps down as MD to lead IMT; Barker becomes sole leader 2026 ARLeadership transition
24 Apr 2026Interim dividend 1.5c paid 2026 ARShareholder return
5 May 2026KFC settlement notices sent to group members shine.com.auSettlement administration
FY26First NZ class action win (Hino Motors); A$40m IMT funding facility; Thai entity; AMP Super and SA Sunday penalty rates actions filed 2026 ARInternational and pipeline build-out
1 Jul 2026FY27 NED rights issued (Bradley 122,057; Dyson 23,561) Motley FoolDirector equity alignment
23 Jul 2026FY26 results date set for 28 Aug 2026 financialfilings.comRoutine
21 Aug 2026Legacy class action written down by A$13.0m (A$13.7m total) after unexpected interlocutory judgment; appeal under consideration ASX; Law360; LawyerlyFifth consecutive year with a material one-off
28 Aug 2026FY26 results: statutory NPAT A$6.7m; adjusted NPAT A$15.8m (+62.9%); 2.5c final; Annual Report and Corporate Governance Statement lodged 2026 AR; Investing.comUnderlying recovery; shares +6.8% to A$0.63
Sep 2026KFC settlement final approval hearing scheduled 9NewsCA cash catalyst
Mid-Sep 2026Shares rally to A$0.77 high (52-week range A$0.565–0.77) InvestSMARTPost-results re-rating
28 Sep 2026Shares go ex-dividend (–10%) InvestSMARTTechnical
2 Oct 2026Current buy-back authority expires ASX noticeCapital management decision point
14 Oct 2026FY26 final dividend 2.5c paid Appendix 4EShareholder return
Oct 2026AGM; David Bayes retires 2026 ARBoard renewal

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

5 charts
Income Statement: Revenue & Gross Profit: Revenue fell from AUD 215.1 Mn in FY2022 to AUD 209.2 Mn in FY2026.
Shine Justice Ltd — Income Statement: Revenue & Gross Profit
Series (AUD Mn)FY2022FY2023FY2024FY2025FY2026
Revenue215.1226.2195.7204.4209.2

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.